Skip to Main Content

FDA-cleared software for advanced brain tumor analyses

Powered by AI and advanced diffusion MRI, NeuroQuant® Brain Tumor assists radiologists, oncologists, and the Tumor Board by providing objective quantification and analysis of tumor changes over time.

Precision AI

NeuroQuant® Brain Tumor enables more precise quantification and visualization of brain tumors with 3D volumetrics.

Play video

Benefits

High- and low-grade glioma

Slice by slice tumor segmentation in DICOM format

Longitudinal disease assessment

Automated quantification and tracking of pre- and post-treatment brain tumor volumes across time

Clinical trial support

Objective tumor quantification for improved confidence and efficiency

Unique microstructure insights

Patented Restriction Spectrum Imaging (RSI) advanced diffusion technology